Home/Filings/4/0000950170-25-078043
4//SEC Filing

Egholm Michael 4

Accession 0000950170-25-078043

CIK 0001162194other

Filed

May 26, 8:00 PM ET

Accepted

May 27, 8:28 PM ET

Size

5.3 KB

Accession

0000950170-25-078043

Insider Transaction Report

Form 4
Period: 2025-05-22
Egholm Michael
DirectorPresident & CEO
Transactions
  • Sale

    Common Stock

    2025-05-22$1.00/sh5,116$5,1262,746,664 total
Footnotes (2)
  • [F1]The shares were sold to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units granted to the reporting person on March 21, 2025, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission ("SEC") on March 24, 2025.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $0.9403 to $1.03 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the SEC, the Issuer, or a security holder of the Issuer.

Documents

1 file

Issuer

STANDARD BIOTOOLS INC.

CIK 0001162194

Entity typeother

Related Parties

1
  • filerCIK 0001559779

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 8:28 PM ET
Size
5.3 KB